Mifepristone as a pharmacological intervention for stress-Induced alcohol craving: a translational crossover randomized trial

No abstract is available for this paper.

• Publication year

  2023

• Venue

  medRxiv

• Publication date

  2023-01-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1101/2023.01.02.23284122PMID 36711869PMCID PMC9882427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies

  2022cited by this paper
• An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder

  2021cited by this paper
• Genetically Selected Alcohol-Preferring msP Rats to Study Alcohol Use Disorder: Anything Lost in Translation?

  2021cited by this paper
• Translational opportunities in animal and human models to study alcohol use disorder

  2021cited by this paper
• Alcohol-related changes in behaviors and characteristics from the baseline to the randomization session for treatment and non-treatment seeking participants with alcohol use disorder

  2021cited by this paper
• An integrated approach to understand biological stress system dysregulation across depressive and anxiety disorders.

  2021cited by this paper
• Effect of Glucocorticoid Receptor Antagonism on Alcohol Self-Administration in Genetically-Selected Marchigian Sardinian Alcohol-Preferring and Non-Preferring Wistar Rats

  2021cited by this paper
• Mifepristone Decreases Chronic Voluntary Ethanol Consumption in Rhesus Macaques

  2020cited by this paper
• Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study.

  2019cited by this paper
• Addiction and stress: An allostatic view.

  2019cited by this paper
• CONSORT 2010 statement: extension to randomised crossover trials

  2019cited by this paper
• Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study

  2018cited by this paper
• Noradrenergic targets for the treatment of alcohol use disorder

  2018cited by this paper
• Combined Analysis of Mifepristone for Psychotic Depression: Plasma Levels Associated With Clinical Response.

  2018cited by this paper
• Two-condition within-participant statistical mediation analysis: A path-analytic framework.

  2017cited by this paper
• A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers☆

  2017cited by this paper
• Role of the α1 blocker doxazosin in alcoholism: a proof‐of‐concept randomized controlled trial

  2016cited by this paper
• Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals.

  2015cited by this paper
• Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation.

  2014cited by this paper
• Pharmacological Approaches to Reducing Craving in Patients with Alcohol Use Disorders

  2014cited by this paper
• Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence.

  2014cited by this paper
• Enhancing exposure therapy for PTSD with yohimbine HCL: protocol for a double-blind, randomized controlled study implementing subjective and objective measures of treatment outcome.

  2013cited by this paper
• Alterations in ethanol seeking and self-administration following yohimbine in selectively bred alcohol-preferring (P) and high alcohol drinking (HAD-2) rats.

  2013cited by this paper
• Bacchus by Caravaggio as the Visual Diagnosis of Alcohol Use Disorder from the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

  2013cited by this paper
• A human laboratory pilot study with baclofen in alcoholic individuals.

  2013cited by this paper
• Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals

  2012cited by this paper
• Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity

  2012cited by this paper
• When can categorical variables be treated as continuous? A comparison of robust continuous and categorical SEM estimation methods under suboptimal conditions.

  2012cited by this paper
• Mifepristone in the Central Nucleus of the Amygdala Reduces Yohimbine Stress-Induced Reinstatement of Ethanol-Seeking

  2012cited by this paper
• Does family history of alcoholism moderate naltrexone's effects on alcohol use?

  2011cited by this paper
• Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate

  2011cited by this paper
• CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

  2010cited by this paper
• The Potent Effect of Environmental Context on Relapse to Alcohol-Seeking After Extinction.

  2010cited by this paper
• PRECLINICAL STUDY: Conditioned cues and yohimbine induce reinstatement of beer and near‐beer seeking in Long‐Evans rats

  2009cited by this paper
• Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.

  2008cited by this paper
• Enhanced Sensitivity to Stress and Drug/Alcohol Craving in Abstinent Cocaine-Dependent Individuals Compared to Social Drinkers

  2008cited by this paper
• Context is a trigger for relapse to alcohol.

  2006cited by this paper
• Tolerance and Variance Inflation Factor

  2005cited by this paper
• Stimulus conditioned to foot-shock stress reinstates alcohol-seeking behavior in an animal model of relapse

  2003cited by this paper
• Central noradrenergic neurones and stress.

  1995cited by this paper
• Development and initial validation of a measure of drinking urges in abstinent alcoholics.

  1995cited by this paper
• Cue elicited urge to drink and salivation in alcoholics: Relationship to individual differences

  1992cited by this paper
• Adrenergic and cholinergic regulation of cortisol secretion from the zona fasciculata/reticularis of bovine adrenal cortex.

  1991cited by this paper
• Cue reactivity in addictive behaviors: theoretical and treatment implications.

  1990cited by this paper
• From theory to practice: the planned treatment of drug users. Interview by Stanley Einstein.

  1990cited by this paper
• What is presented, and what prevented, in cue exposure and response prevention with alcohol dependent subjects?

  1990cited by this paper
• Longitudinal data analysis for discrete and continuous outcomes.

  1986cited by this paper
• Reliability of a family tree questionnaire for assessing family history of alcohol problems.

  1985cited by this paper
• Salivary Cortisol: A Better Measure of Adrenal Cortical Function than Serum Cortisol

  1983cited by this paper

• Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder

  2024cites this paper